2025 annual financial data
Silence Therapeutics 2025 Operating margin
Silence Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was -16,055.99%.
Operating income was -89,753,000 USD and net income was -88,612,000 USD.
Operating cash flow was -62,271,000 USD.
Get free Silence Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 559,000 USD
- Operating income
- -89,753,000 USD
- Net income
- -88,612,000 USD
- Operating cash flow
- -62,271,000 USD